0001209191-23-058570.txt : 20231213
0001209191-23-058570.hdr.sgml : 20231213
20231213204945
ACCESSION NUMBER: 0001209191-23-058570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231211
FILED AS OF DATE: 20231213
DATE AS OF CHANGE: 20231213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xie Jian
CENTRAL INDEX KEY: 0001819718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 231485381
MAIL ADDRESS:
STREET 1: C/O FULGENT GENETICS, INC.
STREET 2: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-11
0
0001674930
Fulgent Genetics, Inc.
FLGT
0001819718
Xie Jian
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE
EL MONTE
CA
91731
0
1
0
0
President and COO
0
Common Stock
2023-12-11
4
S
0
10000
26.3179
D
375124
D
Common Stock
2023-12-11
4
S
0
12000
26.6895
D
363124
D
Common Stock
220816
I
By Trust
The shares were sold in multiple transactions at prices ranging from $26.26 to $26.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $26.61 to $26.92, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
/s/ Paul Kim as Attorney-in-Fact
2023-12-13